𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Histological and clinical outcome after liver transplantation for hepatitis C

✍ Scribed by MC Shuhart; MP Bronner; DR Gretch; LV Thomassen; CF Wartelle; H Tateyama; SS Emerson; JD Perkins; RL Carithers Jr

Book ID
118686778
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
191 KB
Volume
26
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Histological and clinical outcome after
Histological and clinical outcome after liver transplantation for hepatitis C
✍ M C Shuhart; M P Bronner; D R Gretch; L V Thomassen; C F Wartelle; H Tateyama; S πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 1 views

Hepatitis frequently recurs after liver transplantation for early recurrence is associated with a higher risk of disease progression. (HEPATOLOGY 1997;26:1646-1652.) hepatitis C. However, the histological progression of disease, predictors of recurrence and disease severity, and patient survival rem

Histological recurrent hepatitis C after
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation
✍ Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Massimo Del Gaudio; Matteo C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 1 views

Impact of hepatitis C virus (HCV) recurrence on long-term outcome after orthotopic liver transplantation (OLT) is highly variable, and the role of retransplantation is still debated. From 1996 to 2003, 131 OLT with histologically proven HCV recurrence and 6 months of follow-up were retrospectively r

Clinical and histological efficacy of pe
Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation
✍ Inmaculada FernΓ‘ndez; Juan Carlos Meneu; Francisco Colina; Ignacio GarcΓ­a; Raque πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 2 views

Treatment of recurrent hepatitis C in liver transplant is controversial. The aim of our study was to evaluate the clinical and histological efficacy of pegylated interferon alpha 2b (PEG-IFN) and ribavirin therapy of recurrent hepatitis C after liver transplantation (LT). We prospectively included 4